5-Amino-1MQ 50mg research vial
5-Amino-1MQ 50mg research vial: 5-Amino-1MQ, a small molecule built to switch off the enzyme NNMT, studied in cells and mice; its record at Peptides Hanoi is four PubMed papers, from 2018 to 2024: three animal studies and one review.
3,600,000 VND ($140 USD) for 1 vial
Stock and the total are confirmed on WhatsApp.
USD prices are the store's dollar prices; you pay the VND price.
Free tracked delivery to Hanoi in 1 to 3 days, no minimum order. Each vial comes with a bottle of bacteriostatic water and a container. Research use only: not an approved medicine, and no medical advice.
What is 5-Amino-1MQ?
5-Amino-1MQ 50mg is no peptide at all but a small molecule, built in the lab to switch off an enzyme called NNMT. Its research is cell and mouse work plus reviews, and no human trial has been published.
Its chemical name, 5-amino-1-methylquinolinium, explains the abbreviation. NNMT works in fat and liver cells, where it draws down one of the raw materials the body uses to make NAD+. Shutting it off is the idea behind this compound.
Like SLU-PP-332 just before it, this is a small molecule, not a peptide, sold here as a research compound.
What the 4 PubMed papers cited for 5-Amino-1MQ looked at, 2018 to 2024
NNMT blockers from the chemical family of 5-Amino-1MQ were tried in obese mice in 2018, with weight, fat, cholesterol and food intake as the measures.
In a 2024 study that names it outright, as 5A1MQ, obese mice were followed for 28 days, with weight gain, blood sugar and liver fat measured.
In 2022, obese mice on a diet low in fat were given the compound or the diet alone, and the study measured how long they took to reach a lean weight.
A 2024 review of NNMT found that no NNMT blocker had yet reached a reported clinical trial. Every study cited here is in mice; the review covers research on the enzyme.
Sources: Biochem Pharmacol 2018; Diabetes Obes Metab 2024; Sci Rep 2022; Front Pharmacol 2024.
Reading the 5-Amino-1MQ record
5-Amino-1MQ is a small molecule with a clear target and a short record. The target is NNMT, an enzyme that draws down one of the raw materials of NAD+. The record is mouse work, and the earliest paper worked with its chemical relatives, not with this compound by name.
The 2024 mouse study is the one that names it, over 28 days. The 2024 review then noted that no NNMT blocker has reached a reported clinical trial.
The 2024 study, 28 days long, spelled the name 5A1MQ. In the 2022 study the compound always came with a diet low in fat, so anything it measured belongs to the combination. Through its target it connects to the NAD+ 1000mg page: NNMT draws down one of the raw materials of NAD+.
Questions about 5-Amino-1MQ
Is 5-Amino-1MQ a peptide or a small molecule?
A small molecule. Its full chemical name is 5-amino-1-methylquinolinium, and it switches off the enzyme NNMT.
Is there any human trial of 5-Amino-1MQ?
None. According to a 2024 review, no NNMT blocker had yet reached a reported clinical trial.
What does 5-Amino-1MQ do?
In lab work it switches off NNMT, an enzyme in fat and liver cells that draws down one of the raw materials the body uses to make NAD+. Its studies so far used cells and mice.
5-Amino-1MQ 50mg prices
| Pack | Total | Each vial | Per mg |
|---|---|---|---|
| 1 vial | 3,600,000 VND ($140 USD) | 3,600,000 VND ($140 USD) | 72,000 VND ($2.80 USD) |
| Pack of 3 | 8,748,000 VND ($340.20 USD) | 2,916,000 VND ($113.40 USD) | 58,320 VND ($2.27 USD) |
| Pack of 5 | 12,960,000 VND ($504 USD) | 2,592,000 VND ($100.80 USD) | 51,840 VND ($2.02 USD) |
| Pack of 10 | 21,600,000 VND ($840 USD) | 2,160,000 VND ($84 USD) | 43,200 VND ($1.68 USD) |
Near 5-Amino-1MQ in the list of 42
5-Amino-1MQ follows SLU-PP-332 5mg and precedes Tirzepatide 20mg, a compound with one of the largest human records in the catalogue.
- PT-141 10mg, 3,600,000 VND ($140 USD) a vial
- SLU-PP-332 5mg, 4,700,000 VND ($185 USD) a vial
- Tirzepatide 20mg, 2,400,000 VND ($95 USD) a vial
- Retatrutide 20mg, 2,600,000 VND ($102 USD) a vial